Literature DB >> 7499889

The assessment of antibody affinity distribution by thiocyanate elution: a simple dose-response approach.

M U Ferreira1, A M Katzin.   

Abstract

We describe a simple dose-response approach to assess the affinity distribution of polyclonal antibodies. The proportion of antigen-specific antibodies dissociated by increasing concentrations of the mild chaotropic agent ammonium thiocyanate (NH4SCN) was measured by enzyme immunoassay, and the distribution of tolerances to this agent was presented in a histogram form. Such 'tolerance distribution', which is analogous to that described in classical dose-response bioassays, is proposed as a representation of the actual antibody affinity distribution. To test this approach, we assessed affinity maturation patterns of anti-Plasmodium falciparum IgG antibodies in paired sera obtained from 22 malaria patients during the acute infection and convalescence. We obtained patterns of antibody affinity distributions consistent with those previously described in immunization experiments with the aid of more complex laboratory and computational approaches. Therefore, we suggest the thiocyanate elution technique as an alternative method for rapid assessment of affinity distributions of polyclonal antibodies elicited against complex antigens, readily applicable to large number of serum samples.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499889     DOI: 10.1016/0022-1759(95)00186-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  Colostrum of healthy mothers contains broad spectrum of secretory IgA autoantibodies.

Authors:  Jaroslava Pribylova; Klara Krausova; Ingrid Kocourkova; Pavel Rossmann; Klara Klimesova; Miloslav Kverka; Helena Tlaskalova-Hogenova
Journal:  J Clin Immunol       Date:  2012-07-10       Impact factor: 8.317

2.  Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans.

Authors:  C P Quan; A Berneman; R Pires; S Avrameas; J P Bouvet
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.

Authors:  Jairo A Fonseca; Jessica N McCaffery; Juan Caceres; Elena Kashentseva; Balwan Singh; Igor P Dmitriev; David T Curiel; Alberto Moreno
Journal:  Vaccine       Date:  2018-04-12       Impact factor: 3.641

4.  Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.

Authors:  Afton L Thompson; Brandi T Johnson; Gregory D Sempowski; Michael D Gunn; Baidong Hou; Anthony L DeFranco; Herman F Staats
Journal:  J Immunol       Date:  2012-02-15       Impact factor: 5.422

5.  A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.

Authors:  Jairo A Fonseca; Jessica N McCaffery; Elena Kashentseva; Balwan Singh; Igor P Dmitriev; David T Curiel; Alberto Moreno
Journal:  Vaccine       Date:  2017-05-05       Impact factor: 3.641

6.  Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli.

Authors:  Nasr-Eldin M Aref; A Mahdi Saeed
Journal:  Vaccine       Date:  2012-07-02       Impact factor: 3.641

7.  Incorporation of antigens into viral capsids augments immunogenicity of adeno-associated virus vector-based vaccines.

Authors:  Jan Rybniker; Angela Nowag; Hanna Janicki; Kai Demant; Pia Hartmann; Hildegard Büning
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Changes in avidity and level of immunoglobulin G antibodies to Mycobacterium tuberculosis in sera of patients undergoing treatment for pulmonary tuberculosis.

Authors:  Lenka M Pereira Arias-Bouda; Sjoukje Kuijper; Anouk Van der Werf; Lan N Nguyen; Henk M Jansen; Arend H J Kolk
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  Investigation of factors influencing the immunogenicity of hCG as a potential cancer vaccine.

Authors:  N Kvirkvelia; N Chikadze; J Makinde; J D McBride; N Porakishvili; F A Hills; P M Martensen; J Justesen; P J Delves; T Lund; I M Roitt
Journal:  Clin Exp Immunol       Date:  2018-05-07       Impact factor: 4.330

10.  Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine.

Authors:  Marco Tamborrini; Markus S Mueller; Sabine A Stoffel; Nicole Westerfeld; Denise Vogel; Francesca Boato; Rinaldo Zurbriggen; John A Robinson; Gerd Pluschke
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.